Chinook Therapeutics Inc investor relations material

Chinook Therapeutics Inc (Chinook) is a clinical-stage biotechnology company focused on the discovery and development of precision medicines for kidney diseases. The Company's product pipeline comprises of novel drug candidates in various stages of development for the treatment of kidney disease associated with type 2 diabetes. Chinook Therapeutics Inc. is headquartered in Seattle, Washington.